Skip to content
Subscriber Only

Alzheimer’s Research Effort Seeks New Treatments by 2025

An $80 million national research plan to attack Alzheimer’s, a mind-robbing malady that may affect as many as 16 million Americans by 2050, will start this year with U.S.-sponsored studies on ways to prevent the disease in high-risk people, and treat it with an insulin nasal spray.

The National Institutes of Health will spend $7.9 million testing the spray, and $16 million on the first study to focus on growth of the disease in high-risk patients, the Health and Human Services Department said today. The study in those most likely to get Alzheimer’s will be run by Roche Holding AG, using the Swiss company’s experimental drug crenezumab.